CDK4/CEN12 CISH Probe

Catalog # CG0003

Size

Price

Stock

Quantity

Size:400 uL
Price: USD $ 1,277.00
Stock:
order now, ship in 2 weeks
abnova-minus
abnova-plus

* The price is valid only in USA. Please select country.

Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
Images
Chromogenic <i>In Situ</i> Hybridization (FFPE Tissue)
Application

Chromogenic In Situ Hybridization (FFPE Tissue)

Liposarcoma tissue section with CDK4 amplification as indicated by large green clusters.

  • Specification

    Product Description

    CDK4/CEN12 CISH Probe is designed for the qualitative detection of human CDK4 gene amplifications as well as the detection of chromosome 12 alpha satellites in formalin-fixed, paraffin-embedded specimens by chromogenic in situ hybridization (CISH).

    Reactivity

    Human

    Recommend Usage

    The product is ready-to-use. No reconstitution, mixing, or dilution is required. Bring probe to room temperature (18-25°C) and mix briefly before use.

    Supplied Product

    Reagent Provided:

    This Probe is composed of:
    1. Digoxigenin-labeled polynucleotides, which target sequences mapping in 12q13.3-q14.1* (chr12:58,004,553-58,313,271) harboring the CDK4 gene region.
    2. Dinitrophenyl-labeled polynucleotides, which target sequences mapping in 12p11.1-q11 specific for the alpha satellite centromeric region D12Z3 of chromosome 12.
    3. Formamide based hybridization buffer.

    *according to Human Genome Assembly GRCh37/hg19

    Probe Position

    Regulatory Status

    For research use only (RUO)

    Storage Instruction

    Store at 2-8°C in an upright position. Return to storage conditions immediately after use.

    Note

    The probe is intended to be used in combination with the CISH Implementation Kit 2 (Catalog #: KA5366), which provides necessary reagents for specimen pretreatment and post-hybridization processing.

    Interpretation of results:
    Using the CISH Implementation Kit 2 (Cat # KA5366), hybridization signals of Digoxigenin-labeled polynucleotides appear as dark green colored distinct dots (CDKN2A gene region), and Dinitrophenyl-labeled polynucleotides appear as bright red colored distinct dots (CEN 9).
    Normal situation: In interphases of normal cells or cells without a deletion involving the CDKN2A gene region, two distinct dot-shaped green and two distinct dot-shaped red signals appear.
    Aberrant situation: In a cell with deletion affecting the CDKN2A gene region, a reduced number of green signals will be observed. Deletions affecting only parts of the CDKN2A gene region might result in normal signal pattern with green signals of reduced size.
    Overlapping signals may appear as brown signals. Other signal patterns than those described above may be observed in some abnormal samples. These unexpected signal patterns should be further investigated.

    Interpretation of Result

  • Applications

    Chromogenic In Situ Hybridization (FFPE Tissue)

    Liposarcoma tissue section with CDK4 amplification as indicated by large green clusters.
  • Gene Info — CDK4

    Entrez GeneID

    1019

    Gene Name

    CDK4

    Gene Alias

    CMM3, MGC14458, PSK-J3

    Gene Description

    cyclin-dependent kinase 4

    Omim ID

    123829 609048

    Gene Ontology

    Hyperlink

    Gene Summary

    The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. [provided by RefSeq

    Other Designations

    cell division kinase 4|melanoma cutaneous malignant, 3

  • Interactome
  • Pathway
  • Disease
Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
4 Products to Compare
Remove All